A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

NCT06891560 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Adenoid Cystic Carcinoma

Interventions

DRUG: Enfortumab Vedotin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]